The Determination of VEGF and MVD, among Patients with Primary Breast Cancer

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pathology and Oncology Research

• Publication date

  2008-04-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12253-008-9040-1PMID 18398702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum vascular endothelial growth factor in breast cancer.

  2007cited by this paper
• Prognostic molecular markers in early breast cancer

  2004cited by this paper
• Does diet affect breast cancer risk?

  2004cited by this paper
• Comparison of vascularity and angiogenesis in primary invasive mammary carcinomas and in their respective axillary lymph node metastases

  2004cited by this paper
• Prognostic significance of angiogenesis in superficial bladder cancer

  2004cited by this paper
• Ductal carcinoma in situ (DCIS): are we overdetecting it?

  2004cited by this paper
• Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer.

  2004cited by this paper
• Chondrosarcoma of the pubis imitating bladder tumor radiologically: A case report

  2004cited by this paper
• Vascular Endothelial Growth Factor in Breast Cancer

  2004cited by this paper
• Serum VEGF levels in women with a benign breast tumor or breast cancer

  2004cited by this paper
• Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors

  2004cited by this paper
• Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis.

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?

  2003cited by this paper
• Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment

  2003cited by this paper
• Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients

  2003cited by this paper
• Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers

  2003cited by this paper
• [Significance of microvascular density and vascular endothelial growth factor in breast cancer].

  2003cited by this paper
• VEGF and the quest for tumour angiogenesis factors

  2002cited by this paper
• Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.

  2002cited by this paper
• An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.

  2002cited by this paper
• Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients.

  2002cited by this paper
• Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.

  2002cited by this paper
• Clinical Significance of Angiogenic Factor Expression at the Deepest Invasive Site of Advanced Colorectal Carcinoma

  2002cited by this paper
• Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.

  2002cited by this paper
• Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma

  2002cited by this paper
• The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.

  2002cited by this paper
• Valkovic, T. et al. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinomas. Virchows Arch. 440, 583-588

  2002cited by this paper
• Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status.

  2001cited by this paper
• Angiogenesis-dependent diseases.

  2001cited by this paper
• Role of vascular endothelial growth factor in regulation of physiological angiogenesis.

  2001cited by this paper
• Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma.

  2000cited by this paper
• Tumor microvessel density and prognosis in node‐negative breast cancer

  2000cited by this paper
• Functions of the VEGF/VEGF Receptor System in the Vascular System

  2000cited by this paper
• High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

  2000cited by this paper
• Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma.

  2000cited by this paper
• p53 and vascular‐endothelial‐growth‐factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma

  2000cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.

  2000cited by this paper
• Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

  2000cited by this paper
• Elevated levels of angiogenic cytokines in the plasma of cancer patients

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• VEGF overexpression in clinically localized prostate tumors and neuropilin‐1 overexpression in metastatic forms

  2000cited by this paper
• Vascular grading of angiogenesis: prognostic significance in breast cancer

  2000cited by this paper
• Vascular endothelial growth factor: molecular and biological aspects.

  1999cited by this paper
• Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

  1999cited by this paper
• Molecular and biological properties of vascular endothelial growth factor

  1999cited by this paper
• Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis.

  1999cited by this paper
• Tumor angiogenesis as a prognostic factor in laryngeal cancer.

  1997cited by this paper
• Mechanisms of angiogenesis

  1997cited by this paper
• Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients.

  1996cited by this paper
• Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3.

  1996influential reference
• Quantitative analysis of vascular endothelial growth factor in primary breast cancer

  1996cited by this paper
• Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

  1995cited by this paper
• Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen.

  1995cited by this paper
• Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer.

  1995cited by this paper
• Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.

  1993cited by this paper
• Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

  1992cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper

• Predictive value of preoperative CT enhancement rate and CT perfusion parameters in colorectal cancer

  2024cites this paper
• Study of microvascular density in carcinoma of breast

  2024cites this paper
• Potential of natural flavonoids to target breast cancer angiogenesis (review)

  2023influential citation
• Vascular endothelial growth factor –A (VEGF-A) expression as a prognostic factor in breast cancer

  2020cites this paper
• Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-A in patients with primary non-small-cell lung cancer

  2019cites this paper
• Correlations Among Ultrasound‐Guided Diffuse Optical Tomography, Microvessel Density, and Breast Cancer Prognosis

  2018cites this paper
• Dynamic relationship between SIPA1 gene and protein expression and the development of gastric cancer.

  2017cites this paper
• Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo.

  2013cites this paper
• Acquired tamoxifen resistance and promotion of angiogenic responses in breast cancer

  2012cites this paper
• Study of the vascular endothelial growth factor (VEGF) expression and microvascular density (MVD) in primary colorectal cancer specimens.

  2012cites this paper
• CORRELATIONS BETWEEN VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION, MICROVASCULAR DENSITY IN TUMOR TISSUES AND TNM STAGING IN BREAST CANCER

  2012cites this paper
• Characteristics of invasive breast ductal carcinoma, NOS, diagnosed in a tertiary institution in the East Coast of Malaysia with a focus on tumor angiogenesis.

  2012cites this paper
• Expression and clinical significance of vascular endothelial growth factor in benign and malignant tissues of breast

  2008cites this paper